253 related articles for article (PubMed ID: 30590622)
41. High-dose ganciclovir in HHV-6 encephalitis of an immunocompetent child.
Olli-Lähdesmäki T; Haataja L; Parkkola R; Waris M; Bleyzac N; Ruuskanen O
Pediatr Neurol; 2010 Jul; 43(1):53-6. PubMed ID: 20682205
[TBL] [Abstract][Full Text] [Related]
42. [HHV-6 encephalopathy].
Kawamura Y; Yoshikawa T
Nihon Rinsho; 2011 Mar; 69(3):423-8. PubMed ID: 21400833
[TBL] [Abstract][Full Text] [Related]
43. Severe encephalomyelitis in an immunocompetent adult with chromosomally integrated human herpesvirus 6 and clinical response to treatment with foscarnet plus ganciclovir.
Troy SB; Blackburn BG; Yeom K; Caulfield AK; Bhangoo MS; Montoya JG
Clin Infect Dis; 2008 Dec; 47(12):e93-6. PubMed ID: 18991511
[TBL] [Abstract][Full Text] [Related]
44. Retrospective case analysis of antiviral therapies for HHV-6 encephalitis after hematopoietic stem cell transplantation.
Toomey D; Phan TL; Nguyen V; Phan TT; Ogata M
Transpl Infect Dis; 2021 Feb; 23(1):e13443. PubMed ID: 32786154
[TBL] [Abstract][Full Text] [Related]
45. Severe encephalitis in a haematopoietic stem cell transplant recipient caused by reactivation of human herpesvirus 6 and 7.
Holden SR; Vas AL
J Clin Virol; 2007 Nov; 40(3):245-7. PubMed ID: 17913577
[No Abstract] [Full Text] [Related]
46. [Human herpesvirus 6 encephalitis after bone marrow transplantation].
Pop-Jora D; Berhoune C; Najioullah F; Girard S; Mialou V; Bleyzac N; Galambrun C; Bertrand Y
Arch Pediatr; 2006 Dec; 13(12):1518-20. PubMed ID: 17092696
[TBL] [Abstract][Full Text] [Related]
47. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient.
Paterson DL; Singh N; Gayowski T; Carrigan DR; Marino IR
Liver Transpl Surg; 1999 Sep; 5(5):454-5. PubMed ID: 10477848
[TBL] [Abstract][Full Text] [Related]
48. Delayed human herpes virus 6 encephalitis in a patient with allogeneic stem cell transplant.
O'Toole J; Ades S; Waters BL; Agarwal Z; Lamba G
Leuk Lymphoma; 2015; 56(9):2709-10. PubMed ID: 25629987
[No Abstract] [Full Text] [Related]
49. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
[TBL] [Abstract][Full Text] [Related]
50. Chromosomally integrated human herpesvirus-6 in transplant recipients.
Lee SO; Brown RA; Razonable RR
Transpl Infect Dis; 2012 Aug; 14(4):346-54. PubMed ID: 22321264
[TBL] [Abstract][Full Text] [Related]
51. Human Herpesvirus 6 encephalitis in an immunocompetent pregnant patient and review of the literature.
Yilmaz M; Yasar C; Aydin S; Derin O; Polat B; Ertan G; Ceylan B; Mert A
Clin Neurol Neurosurg; 2018 Aug; 171():106-108. PubMed ID: 29902636
[TBL] [Abstract][Full Text] [Related]
52. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
[TBL] [Abstract][Full Text] [Related]
53. Human herpesvirus 6 DNA levels in cerebrospinal fluid due to primary infection differ from those due to chromosomal viral integration and have implications for diagnosis of encephalitis.
Ward KN; Leong HN; Thiruchelvam AD; Atkinson CE; Clark DA
J Clin Microbiol; 2007 Apr; 45(4):1298-304. PubMed ID: 17229866
[TBL] [Abstract][Full Text] [Related]
54. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
Ogata M; Takano K; Moriuchi Y; Kondo T; Ueki T; Nakano N; Mori T; Uoshima N; Nagafuji K; Yamasaki S; Shibasaki Y; Sakai R; Kato K; Choi I; Jo Y; Eto T; Kako S; Oshima K; Fukuda T
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1264-1273. PubMed ID: 29454651
[TBL] [Abstract][Full Text] [Related]
55. Roseoloviruses in transplant recipients: clinical consequences and prospects for treatment and prevention trials.
Hill JA; Zerr DM
Curr Opin Virol; 2014 Dec; 9():53-60. PubMed ID: 25285614
[TBL] [Abstract][Full Text] [Related]
56. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system.
Dewhurst S
Herpes; 2004 Jun; 11 Suppl 2():105A-111A. PubMed ID: 15319097
[TBL] [Abstract][Full Text] [Related]
57. [Human herpesvirus 6 encephalitis in trimethoprim-sulfamethoxazole-induced hypersensitivity syndrome].
Mohammedi I; Mausservey C; Hot A; Najioullah F; Kanitakis J; Robert D
Rev Med Interne; 2006 Jun; 27(6):499-501. PubMed ID: 16563571
[TBL] [Abstract][Full Text] [Related]
58. Human herpesvirus 6B encephalitis in a liver transplant recipient: A case report and review of the literature.
Wang Y; Wang D; Tao X
Transpl Infect Dis; 2021 Feb; 23(1):e13403. PubMed ID: 32638491
[TBL] [Abstract][Full Text] [Related]
59. [Human herpesvirus-6 associated with hematopoietic stem cell transplantation].
Ogata M
Rinsho Ketsueki; 2015 Oct; 56(10):2160-9. PubMed ID: 26458456
[TBL] [Abstract][Full Text] [Related]
60. Human herpesvirus-6 infection in solid organ and stem cell transplant recipients.
Ljungman P; Singh N
J Clin Virol; 2006 Dec; 37 Suppl 1():S87-91. PubMed ID: 17276376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
